Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Justice

Showing results (561-570 of 587) with videos related to

Pageof 59
Sort By:
Plos One|August 26, 2020
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran programMarina Serper, Marijana Vujkovic, David E Kaplan, et al.
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Alcohol, Clinical & Experimental Research|June 25, 2026
Exploring Phosphatidylethanol Cutoffs for Self-Reported Unhealthy Alcohol Use: An International Multi-Site AnalysisPamela M Murnane, Fan Xia, Majid Afshar, et al.
Plos One|March 17, 2021
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patientsMark Stewart, Carla Rodriguez-Watson, Adem Albayrak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 19, 2017
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General PopulationDaniel R Drozd, Mari M Kitahata, Keri N Althoff, et al.
Alcoholism, Clinical and Experimental Research|April 10, 2021
Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysisJudith A Hahn, Pamela M Murnane, Eric Vittinghoff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff, Stephen J Gange, Marina B Klein, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomesSylvanus Toikumo, Mariela V Jennings, Benjamin K Pham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Pageof 59

Showing results (561-570 of 587) with videos related to

Sort By:
Pageof 59
Plos One|August 26, 2020
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran programMarina Serper, Marijana Vujkovic, David E Kaplan, et al.
AIDS Research and Therapy|December 17, 2010
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?Keri N Althoff, Kelly A Gebo, Stephen J Gange, et al.
Alcohol, Clinical & Experimental Research|June 25, 2026
Exploring Phosphatidylethanol Cutoffs for Self-Reported Unhealthy Alcohol Use: An International Multi-Site AnalysisPamela M Murnane, Fan Xia, Majid Afshar, et al.
Plos One|March 17, 2021
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patientsMark Stewart, Carla Rodriguez-Watson, Adem Albayrak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North AmericaSteven G Deeks, Stephen J Gange, Mari M Kitahata, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 19, 2017
Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General PopulationDaniel R Drozd, Mari M Kitahata, Keri N Althoff, et al.
Alcoholism, Clinical and Experimental Research|April 10, 2021
Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysisJudith A Hahn, Pamela M Murnane, Eric Vittinghoff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2010
Late presentation for human immunodeficiency virus care in the United States and CanadaKeri N Althoff, Stephen J Gange, Marina B Klein, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Multi-ancestry meta-analysis of tobacco use disorder prioritizes novel candidate risk genes and reveals associations with numerous health outcomesSylvanus Toikumo, Mariela V Jennings, Benjamin K Pham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Pageof 59